General MedicationsSUBLINGUALGeneric

FENTANYL CITRATE

Standard Dose

EQ 0.2MG BASE

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview FENTANYL CITRATE is listed in Drugs@FDA under application 207338 (ANDA).

Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TABLET;SUBLINGUAL - EQ 0.2MG BASE Sponsor ACTAVIS LABS FL INC Submission history Latest submission status date: 2024-08-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview FENTANYL CITRATE is listed in Drugs@FDA under application 207338 (ANDA). Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TABLET;SUBLINGUAL - EQ 0.2MG BASE Sponsor ACTAVIS LABS FL INC Submission history Latest submission status date: 2024-08-28 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.